REN and secondary hyperparathyroidism: Park and colleagues reported that calcitriol, administered intravenously twice weekly over 15 weeks, reduced left ventricular mass and suppressed circulating levels of renin, angiotensin II and ANP in patients on chronic hemodialysis with secondary hyperparathyroidism [22].